Yellow nail syndrome.
Identifieur interne : 009519 ( Ncbi/Merge ); précédent : 009518; suivant : 009520Yellow nail syndrome.
Auteurs : A K Gupta ; G M Davies ; H F HabermanSource :
- Cutis [ 0011-4162 ] ; 1986.
Descripteurs français
- KwdFr :
- Adulte d'âge moyen, Carcinome intracanalaire non infiltrant (), Femelle, Fibrose pulmonaire (), Fibrose pulmonaire (traitement médicamenteux), Humains, Lymphoedème (), Onychopathies (), Onychopathies (traitement médicamenteux), Prednisone (usage thérapeutique), Syndrome (), Troubles de la pigmentation (), Tumeurs du sein (), Épanchement pleural (traitement médicamenteux).
- MESH :
- traitement médicamenteux : Fibrose pulmonaire, Onychopathies, Épanchement pleural.
- usage thérapeutique : Prednisone.
- Adulte d'âge moyen, Carcinome intracanalaire non infiltrant, Femelle, Fibrose pulmonaire, Humains, Lymphoedème, Onychopathies, Syndrome, Troubles de la pigmentation, Tumeurs du sein.
English descriptors
- KwdEn :
- Breast Neoplasms (complications), Carcinoma, Intraductal, Noninfiltrating (complications), Female, Humans, Lymphedema (complications), Middle Aged, Nail Diseases (complications), Nail Diseases (drug therapy), Pigmentation Disorders (complications), Pleural Effusion (drug therapy), Prednisone (therapeutic use), Pulmonary Fibrosis (complications), Pulmonary Fibrosis (drug therapy), Syndrome (complications).
- MESH :
- chemical , therapeutic use : Prednisone.
- complications : Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Lymphedema, Nail Diseases, Pigmentation Disorders, Pulmonary Fibrosis, Syndrome.
- drug therapy : Nail Diseases, Pleural Effusion, Pulmonary Fibrosis.
- Female, Humans, Middle Aged.
Abstract
The case of a patient with yellow nail syndrome (YNS), an infiltrating duct carcinoma of the breast, and giant cell interstitial pneumonitis (GIP) is presented. YNS has not been previously described in association with GIP. There was improvement of the yellow fingernails following surgery and chemotherapy for the breast cancer. The possible pathogenesis of the yellow nails in this case and its management are presented. A wide variety of conditions are associated with YNS, which has been reported to respond to various treatment modalities. The most likely cause in our case is impaired lymphatic drainage. However, treatments that do not affect lymphatic drainage also have been reported to be successful.
PubMed: 3011360
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 006608
- to stream PubMed, to step Curation: 006608
- to stream PubMed, to step Checkpoint: 006608
Links to Exploration step
pubmed:3011360Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Yellow nail syndrome.</title><author><name sortKey="Gupta, A K" sort="Gupta, A K" uniqKey="Gupta A" first="A K" last="Gupta">A K Gupta</name></author><author><name sortKey="Davies, G M" sort="Davies, G M" uniqKey="Davies G" first="G M" last="Davies">G M Davies</name></author><author><name sortKey="Haberman, H F" sort="Haberman, H F" uniqKey="Haberman H" first="H F" last="Haberman">H F Haberman</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="1986">1986</date><idno type="RBID">pubmed:3011360</idno><idno type="pmid">3011360</idno><idno type="wicri:Area/PubMed/Corpus">006608</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">006608</idno><idno type="wicri:Area/PubMed/Curation">006608</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">006608</idno><idno type="wicri:Area/PubMed/Checkpoint">006608</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">006608</idno><idno type="wicri:Area/Ncbi/Merge">009519</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Yellow nail syndrome.</title><author><name sortKey="Gupta, A K" sort="Gupta, A K" uniqKey="Gupta A" first="A K" last="Gupta">A K Gupta</name></author><author><name sortKey="Davies, G M" sort="Davies, G M" uniqKey="Davies G" first="G M" last="Davies">G M Davies</name></author><author><name sortKey="Haberman, H F" sort="Haberman, H F" uniqKey="Haberman H" first="H F" last="Haberman">H F Haberman</name></author></analytic><series><title level="j">Cutis</title><idno type="ISSN">0011-4162</idno><imprint><date when="1986" type="published">1986</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Breast Neoplasms (complications)</term><term>Carcinoma, Intraductal, Noninfiltrating (complications)</term><term>Female</term><term>Humans</term><term>Lymphedema (complications)</term><term>Middle Aged</term><term>Nail Diseases (complications)</term><term>Nail Diseases (drug therapy)</term><term>Pigmentation Disorders (complications)</term><term>Pleural Effusion (drug therapy)</term><term>Prednisone (therapeutic use)</term><term>Pulmonary Fibrosis (complications)</term><term>Pulmonary Fibrosis (drug therapy)</term><term>Syndrome (complications)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Carcinome intracanalaire non infiltrant ()</term><term>Femelle</term><term>Fibrose pulmonaire ()</term><term>Fibrose pulmonaire (traitement médicamenteux)</term><term>Humains</term><term>Lymphoedème ()</term><term>Onychopathies ()</term><term>Onychopathies (traitement médicamenteux)</term><term>Prednisone (usage thérapeutique)</term><term>Syndrome ()</term><term>Troubles de la pigmentation ()</term><term>Tumeurs du sein ()</term><term>Épanchement pleural (traitement médicamenteux)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Prednisone</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Breast Neoplasms</term><term>Carcinoma, Intraductal, Noninfiltrating</term><term>Lymphedema</term><term>Nail Diseases</term><term>Pigmentation Disorders</term><term>Pulmonary Fibrosis</term><term>Syndrome</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Nail Diseases</term><term>Pleural Effusion</term><term>Pulmonary Fibrosis</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Fibrose pulmonaire</term><term>Onychopathies</term><term>Épanchement pleural</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Prednisone</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Female</term><term>Humans</term><term>Middle Aged</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Carcinome intracanalaire non infiltrant</term><term>Femelle</term><term>Fibrose pulmonaire</term><term>Humains</term><term>Lymphoedème</term><term>Onychopathies</term><term>Syndrome</term><term>Troubles de la pigmentation</term><term>Tumeurs du sein</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The case of a patient with yellow nail syndrome (YNS), an infiltrating duct carcinoma of the breast, and giant cell interstitial pneumonitis (GIP) is presented. YNS has not been previously described in association with GIP. There was improvement of the yellow fingernails following surgery and chemotherapy for the breast cancer. The possible pathogenesis of the yellow nails in this case and its management are presented. A wide variety of conditions are associated with YNS, which has been reported to respond to various treatment modalities. The most likely cause in our case is impaired lymphatic drainage. However, treatments that do not affect lymphatic drainage also have been reported to be successful.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">3011360</PMID><DateCreated><Year>1986</Year><Month>07</Month><Day>23</Day></DateCreated><DateCompleted><Year>1986</Year><Month>07</Month><Day>23</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0011-4162</ISSN><JournalIssue CitedMedium="Print"><Volume>37</Volume><Issue>5</Issue><PubDate><Year>1986</Year><Month>May</Month></PubDate></JournalIssue><Title>Cutis</Title><ISOAbbreviation>Cutis</ISOAbbreviation></Journal><ArticleTitle>Yellow nail syndrome.</ArticleTitle><Pagination><MedlinePgn>371-4</MedlinePgn></Pagination><Abstract><AbstractText>The case of a patient with yellow nail syndrome (YNS), an infiltrating duct carcinoma of the breast, and giant cell interstitial pneumonitis (GIP) is presented. YNS has not been previously described in association with GIP. There was improvement of the yellow fingernails following surgery and chemotherapy for the breast cancer. The possible pathogenesis of the yellow nails in this case and its management are presented. A wide variety of conditions are associated with YNS, which has been reported to respond to various treatment modalities. The most likely cause in our case is impaired lymphatic drainage. However, treatments that do not affect lymphatic drainage also have been reported to be successful.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gupta</LastName><ForeName>A K</ForeName><Initials>AK</Initials></Author><Author ValidYN="Y"><LastName>Davies</LastName><ForeName>G M</ForeName><Initials>GM</Initials></Author><Author ValidYN="Y"><LastName>Haberman</LastName><ForeName>H F</ForeName><Initials>HF</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cutis</MedlineTA><NlmUniqueID>0006440</NlmUniqueID><ISSNLinking>0011-4162</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>VB0R961HZT</RegistryNumber><NameOfSubstance UI="D011241">Prednisone</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002285" MajorTopicYN="N">Carcinoma, Intraductal, Noninfiltrating</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009260" MajorTopicYN="N">Nail Diseases</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010859" MajorTopicYN="N">Pigmentation Disorders</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010996" MajorTopicYN="N">Pleural Effusion</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011241" MajorTopicYN="N">Prednisone</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011658" MajorTopicYN="N">Pulmonary Fibrosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013577" MajorTopicYN="N">Syndrome</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1986</Year><Month>5</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1986</Year><Month>5</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1986</Year><Month>5</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">3011360</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list></list><tree><noCountry><name sortKey="Davies, G M" sort="Davies, G M" uniqKey="Davies G" first="G M" last="Davies">G M Davies</name><name sortKey="Gupta, A K" sort="Gupta, A K" uniqKey="Gupta A" first="A K" last="Gupta">A K Gupta</name><name sortKey="Haberman, H F" sort="Haberman, H F" uniqKey="Haberman H" first="H F" last="Haberman">H F Haberman</name></noCountry></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 009519 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 009519 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Ncbi
|étape= Merge
|type= RBID
|clé= pubmed:3011360
|texte= Yellow nail syndrome.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:3011360" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |